My ambition is to deliver cost effective management operations to our research teams that match their world leading capabilities. An organisation like the Sanger Institute should be led by the needs of the science and the mantra in Management Operations is to provide simple and effective services that reduce the administrative burden on our researchers, so they can focus on what they do best!
As a senior manager at the Sanger Institute I like to ensure people realise I am approachable. A wise consultant once told me the higher you are in an organisation the less you know about how it actually runs. One way to guard against this is to have a truly “open door” policy!
My timeline
Chief Operating Officer - Wellcome Trust Sanger Institute and Genome Campus
Chief Operating Officer at Medical Research Council Laboratory of Molecular Biology. I had responsibility for leading many of the scientific services and facilities as well as the support functions and business processes at the Institute. We successfully completed the construction and then transitioned 600+ researchers, support staff and their equipment to the new laboratories on the Cambridge Biomedical Campus.
Executive Director at Royal Statistical Society. I led a learned and professional body with 7,500 members. Advancing the science and application of statistics, and promoting use and awareness for public benefit.
Executive Director at RCOG - National Collaborating Centre for Women’s and Children’s Health. Running a health service research team developing clinical and cost-effectiveness guidelines for NICE. My host institute was the Royal College Obstetricians and Gynaecologists.
Director/owner at Pyxis Medical Communications. Providing a marketing and communication service to medical charities and the pharmaceutical industry. Created start-up business with two colleagues.
I was awarded my PhD from the Liverpool School of Tropical Medicine in 1994 and took up a Wellcome Trust Research Fellowship to continue my research into the semiochemistry of the sandfly vector of cutaneous Leishmaniasis.
This report analyses trends in human genomics and the UK market position based, discussions with industry and public sector stakeholders literature review and our work in the sector. It focuses on the United Kingdom but in the context of the global market and draws on examples from other countries.
The topping out ceremony of the new Genome Campus Conference Centre. The Centre is now open for business.
